Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Acrivon Therapeutics, Inc. (ACRV)

2.0300
+0.1200
+(6.28%)
At close: April 22 at 4:00:02 PM EDT
2.0200
-0.01
(-0.49%)
After hours: April 22 at 6:33:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
89,199
89,199
67,103
32,657
16,184
Operating Income
-89,199
-89,199
-67,103
-32,657
-16,184
Net Non Operating Interest Income Expense
9,201
9,201
7,037
--
--
Other Income Expense
-558
-558
-322
1,490
-59
Pretax Income
-80,556
-80,556
-60,388
-31,167
-16,243
Net Income Common Stockholders
-80,556
-80,556
-60,388
-31,167
-16,243
Diluted NI Available to Com Stockholders
-80,556
-80,556
-60,388
-31,167
-16,243
Basic EPS
-2.38
--
-2.74
-7.56
-1.26
Diluted EPS
-2.38
--
-2.74
-7.56
-1.26
Basic Average Shares
33,791.8170
--
22,078.1900
4,121.9120
12,909.8230
Diluted Average Shares
33,791.8170
--
22,078.1900
4,121.9120
12,909.8230
Total Operating Income as Reported
-89,199
-89,199
-67,103
-32,657
-16,184
Total Expenses
89,199
89,199
67,103
32,657
16,184
Net Income from Continuing & Discontinued Operation
-80,556
-80,556
-60,388
-31,167
-16,243
Normalized Income
-80,556
-80,556
-60,388
-31,167
-16,243
Interest Income
9,201
9,201
7,037
--
--
Net Interest Income
9,201
9,201
7,037
--
--
EBIT
-89,199
-89,199
-67,103
-32,657
-16,184
EBITDA
-88,193
-88,193
-66,567
-32,293
-16,147
Reconciled Depreciation
1,006
1,006
536
364
37
Net Income from Continuing Operation Net Minority Interest
-80,556
-80,556
-60,388
-31,167
-16,243
Total Unusual Items Excluding Goodwill
--
--
--
--
-80
Total Unusual Items
--
--
--
--
-80
Normalized EBITDA
-88,193
-88,193
-66,567
-32,293
-16,147
12/31/2021 - 11/15/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LXEO Lexeo Therapeutics, Inc.
3.4200
+6.54%
 
APM Aptorum Group Limited
0.9130
+9.32%
 
SPRB Spruce Biosciences, Inc.
0.1296
+7.02%
 
ARTV Artiva Biotherapeutics, Inc.
2.4500
+2.08%
 
PEPG PepGen Inc.
1.6200
+6.58%
 
DTIL Precision BioSciences, Inc.
5.32
+3.70%
 
PRQR ProQR Therapeutics N.V.
1.3500
+2.27%
 
SKYE Skye Bioscience, Inc.
1.5100
-3.82%
 
MTVA MetaVia Inc.
0.7500
+1.35%
 
KOD Kodiak Sciences Inc.
3.6400
+12.00%